HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Bouvet Selected Research

eribulin

3/2024Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts.
4/2021Eribulin Inhibits Osteosarcoma in a Clinically-accurate Bone-tumor-insertion PDOX Mouse Model.
5/2020A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model.
5/2020Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model.
5/2020A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib.
9/2019Eribulin Suppressed Cisplatinum- and Doxorubicin-resistant Recurrent Lung Metastatic Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Bouvet Research Topics

Disease

279Neoplasms (Cancer)
05/2024 - 03/2002
99Pancreatic Neoplasms (Pancreatic Cancer)
05/2023 - 04/2002
76Neoplasm Metastasis (Metastasis)
08/2023 - 04/2002
46Colonic Neoplasms (Colon Cancer)
05/2024 - 06/2005
38Osteosarcoma (Osteogenic Sarcoma)
12/2023 - 03/2009
19Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 05/2009
16Adenocarcinoma
04/2023 - 04/2002
13Sarcoma (Soft Tissue Sarcoma)
01/2022 - 06/2007
11Fibrosarcoma
03/2024 - 06/2005
9Stomach Neoplasms (Stomach Cancer)
04/2024 - 05/2016
8Prostatic Neoplasms (Prostate Cancer)
07/2022 - 07/2006
8Ewing Sarcoma (Sarcoma, Ewing)
01/2022 - 07/2016
7Necrosis
02/2023 - 12/2015
7Melanoma (Melanoma, Malignant)
11/2020 - 08/2002
6Triple Negative Breast Neoplasms
11/2023 - 12/2016
6Carcinoma (Carcinomatosis)
07/2022 - 10/2010
6Breast Neoplasms (Breast Cancer)
04/2021 - 06/2005
5Liposarcoma
07/2023 - 09/2019
5Parathyroid Neoplasms (Parathyroid Neoplasm)
04/2023 - 07/2007
5Lymphatic Metastasis
02/2022 - 01/2003
4Disease Progression
04/2024 - 11/2014
4Glioma (Gliomas)
12/2023 - 02/2012
3Adenoma (Adenomas)
04/2023 - 11/2003
3Obesity
01/2023 - 05/2020

Drug/Important Bio-Agent (IBA)

78Green Fluorescent ProteinsIBA
01/2023 - 03/2002
74Red Fluorescent ProteinIBA
08/2023 - 07/2003
41L-methionine gamma-lyaseIBA
05/2024 - 09/2014
41Proteins (Proteins, Gene)FDA Link
02/2024 - 04/2002
26Methionine (L-Methionine)FDA Link
05/2024 - 05/2017
26GemcitabineFDA Link
01/2021 - 01/2003
23Doxorubicin (Adriamycin)FDA LinkGeneric
12/2021 - 06/2007
21Carcinoembryonic AntigenIBA
01/2024 - 11/2008
19Coloring Agents (Dyes)IBA
01/2024 - 12/2013
18IntegrinsIBA
01/2019 - 04/2005
16AntibodiesIBA
01/2024 - 01/2008
15Histones (Histone)IBA
04/2022 - 05/2005
13Fluorouracil (Carac)FDA LinkGeneric
02/2023 - 05/2009
11Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2024 - 09/2015
11Monoclonal AntibodiesIBA
11/2023 - 06/2008
11Telomerase (Telomerase Reverse Transcriptase)IBA
12/2016 - 08/2002
9Irinotecan (Camptosar)FDA LinkGeneric
05/2024 - 07/2003
9Biomarkers (Surrogate Marker)IBA
02/2023 - 07/2003
9Indicators and Reagents (Reagents)IBA
02/2023 - 12/2011
9Fluorescent Dyes (Fluorescent Probes)IBA
01/2023 - 11/2011
7Temozolomide (Temodar)FDA LinkGeneric
12/2023 - 01/2013
7CollagenIBA
01/2019 - 03/2007
7Cyan Fluorescent ProteinIBA
01/2016 - 03/2009
7NestinIBA
01/2013 - 06/2005
7Collagen Type I (Type I Collagen)IBA
08/2010 - 01/2005
6eribulinFDA Link
03/2024 - 09/2019
6Cytotoxins (Cytolysins)IBA
05/2023 - 01/2014
6pazopanibFDA Link
09/2021 - 01/2015
6Docetaxel (Taxotere)FDA Link
04/2021 - 07/2012
6AntigensIBA
01/2021 - 06/2008
6Parathyroid Hormone-Related ProteinIBA
07/2006 - 04/2002
5Lysine (L-Lysine)FDA Link
04/2022 - 11/2021
5Sorafenib (BAY 43-9006)FDA Link
01/2022 - 08/2019
5palbociclibIBA
01/2022 - 07/2016
5olaratumabIBA
12/2021 - 01/2019
5Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 01/2014
5LigandsIBA
11/2020 - 08/2003
5Insulin (Novolin)FDA Link
05/2020 - 01/2016
5Peptides (Polypeptides)IBA
12/2019 - 08/2005
5Integrin alpha2beta1IBA
08/2010 - 01/2005
4regorafenibIBA
11/2023 - 01/2019
4MucinsIBA
02/2023 - 01/2021
4Hematoxylin (Haematoxylon)IBA
01/2023 - 01/2018
4Phosphotransferases (Kinase)IBA
11/2022 - 03/2010
4ParaffinIBA
07/2022 - 04/2002
4TrabectedinIBA
12/2021 - 05/2019
4Cell Adhesion MoleculesIBA
07/2021 - 01/2020
4RNA (Ribonucleic Acid)IBA
01/2021 - 01/2015
4130-nm albumin-bound paclitaxelIBA
01/2019 - 05/2015
4Fibronectins (Fibronectin)IBA
08/2013 - 01/2005
4CationsIBA
08/2010 - 01/2005
4Angiogenesis InhibitorsIBA
06/2007 - 06/2005
3Immunoglobulin G (IgG)IBA
01/2024 - 01/2009
3PlasticsIBA
03/2023 - 08/2014
3Eosine Yellowish-(YS) (Eosin)IBA
01/2023 - 07/2021
3Contrast MediaIBA
01/2023 - 01/2012
3Drug CombinationsIBA
01/2022 - 09/2019
3EverolimusFDA Link
01/2022 - 09/2019
3histone H3 trimethyl Lys4IBA
01/2022 - 12/2020

Therapy/Procedure

84Therapeutics
12/2023 - 07/2003
37Drug Therapy (Chemotherapy)
01/2024 - 03/2004
15Transplantation
11/2022 - 05/2006
8Neoadjuvant Therapy
05/2021 - 05/2009
8Laparotomy
11/2020 - 05/2004
8Lasers (Laser)
01/2020 - 11/2010
6Aftercare (After-Treatment)
09/2019 - 05/2009
5Computer-Assisted Surgery (Image Guided Surgery)
01/2023 - 06/2008
5Esophagectomy
01/2021 - 02/2014
5Parathyroidectomy
12/2019 - 11/2003
5Craniotomy
04/2013 - 02/2012
4Oral Administration
01/2023 - 03/2004
4Immunotherapy
05/2022 - 06/2017
4Cell Transplantation
05/2016 - 03/2011
4Thyroidectomy
02/2016 - 07/2007
3Combination Drug Therapy (Combination Chemotherapy)
01/2024 - 01/2016
3Intravenous Administration
01/2022 - 01/2016